Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.
about
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management[Ultrahigh field MRI in context of neurological diseases].Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.Imaging as an Outcome Measure in Multiple Sclerosis.Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosisCognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.Clinical applications at ultrahigh field (7 T). Where does it make the difference?Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration."Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraineOptimization of magnetization-prepared 3-dimensional fluid attenuated inversion recovery imaging for lesion detection at 7 T.Venocentric Lesions: An MRI Marker of MS?Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease.FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?Insights from Ultrahigh Field Imaging in Multiple Sclerosis.Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.SWI enhances vein detection using gadolinium in multiple sclerosis.The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.Comparison of Routine Brain Imaging at 3 T and 7 T.Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.Key clinical benefits of neuroimaging at 7T.Imag(in)ing multiple sclerosis: Time to take better pictures.Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD
P2860
Q26796643-E1077D74-DE79-4AEA-A587-0D2B5FE5C93FQ30759627-2A5957B7-2651-4484-B564-21DA5C3C7A9FQ30831649-C539B28F-0AED-4A1F-9EC5-03E36DF651E3Q31134617-4601BD6F-7BAC-4C73-8EE6-8573D114BAC1Q34203136-05F17E83-E297-473A-B655-69686B5BCF31Q35529255-D7AFA847-CA2D-47E7-AB5E-BAEA629CDF11Q35575469-898BF112-4C0E-445A-9D1E-EA550F368832Q35694584-19ACD9A5-1008-4B1C-A536-F1BC7A1D9891Q36565226-B3AD8857-0595-4466-BE74-ECCAF5994E97Q36856736-C664CFEB-330D-4E80-BC09-45ADD177BA65Q37030461-A44CA6B5-402B-4276-B1AE-A338FDE6F510Q38794656-7281E1FB-B7DB-4B07-87C6-D145746AD4ABQ38930555-47C0501D-212A-4F65-A116-B7138B53CCECQ39229796-E0EEB384-C35D-4849-9CDE-7833D4CB4855Q40220046-D1A35E09-E6F7-45C0-A261-0EE6D3C5B910Q41027045-01FA62D2-734C-4140-AF93-315E2132E7FDQ41654013-8249244E-6EEC-4ED1-AA2D-7F9CA9AB4191Q41988403-27F2932F-087A-43DC-A0B0-18D1C9550711Q42242789-B624CB3B-7503-4542-9750-12FC1D2FC8E6Q43426688-02880F7F-6422-4BD9-973A-2F363D44D4E2Q45961588-765A1844-AB91-4FC5-B9E9-51192BDB7075Q47146663-4CD04C0D-D5FF-4A59-B84A-00D6C010E696Q47721240-7E0F84EA-6863-4E73-8DC8-31B0AEA06510Q47931219-F312B5E1-69AB-4B48-A2DD-FC41FAE65891Q48428333-F0022731-3B7C-4AF1-9CB6-34D6A42EE828Q48478781-A5FB6461-451F-4FFF-8D50-AEE9D5188B6CQ48527262-0EDEBBE9-F635-433C-A330-BA0361DC3EF5Q48678554-701A985B-842C-4E03-A663-389E2E81D540Q52560368-EC330448-F861-4E4E-AA6A-B0597DCB8169Q52877273-73CEA8CC-4202-4E68-B220-CFB5FCBB6E73Q57821323-04A3B8F9-87C7-4D0F-8686-27B973797836
P2860
Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Central veins in brain lesions ...... ry demyelination in the brain.
@en
Central veins in brain lesions ...... ry demyelination in the brain.
@nl
type
label
Central veins in brain lesions ...... ry demyelination in the brain.
@en
Central veins in brain lesions ...... ry demyelination in the brain.
@nl
prefLabel
Central veins in brain lesions ...... ry demyelination in the brain.
@en
Central veins in brain lesions ...... ry demyelination in the brain.
@nl
P2093
P50
P921
P1433
P1476
Central veins in brain lesions ...... ory demyelination in the brain
@en
P2093
Christopher Tench
Jennifer Dixon
Niraj Mistry
Peter Morris
Rasha Abdel-Fahim
Tim Jaspan
P304
P356
10.1001/JAMANEUROL.2013.1405
P407
P577
2013-05-01T00:00:00Z